Arbutus Biopharma Corp (NASDAQ:ABUS)

1.14
Delayed Data
As of Mar 30
 -0.09 / -7.44%
Today’s Change
0.82
Today|||52-Week Range
4.56
-58.99%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close1.21
Today’s open1.29
Day’s range1.10 - 1.29
Volume2,102,409
Average volume (3 months)739,612
Market cap$83.4M
Data as of 7:39pm ET, 03/30/2020

Growth & Valuation

Earnings growth (last year)-137.84%
Earnings growth (this year)+59.38%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.11%
P/E ratioNM
Price/Sales26.40
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...+0.09+3.37%
GNPXGenprex Inc-0.20-7.78%
AQSTAquestive Therapeuti...-0.02-0.87%
CYCNCyclerion Therapeuti...-0.26-8.64%
Data as of 7:45pm ET, 03/30/2020

Financials

Next reporting dateApril 30, 2020
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$6.0M
Annual profit (last year)-$153.7M
Net profit margin-2,557.36%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Warminster, Pennsylvania

Forecasts